Today: 29 April 2026
Browse Category

NASDAQ:RDW 17 September 2025 - 29 January 2026

Redwire stock (RDW) jumps again in premarket after $151B SHIELD award — what traders watch next

Redwire stock (RDW) jumps again in premarket after $151B SHIELD award — what traders watch next

Redwire shares rose 2.4% to $14.54 in Wednesday premarket trading after the company secured a spot on the Missile Defense Agency’s $151 billion SHIELD contract vehicle. The stock jumped 29.6% Tuesday on heavy volume. The contract admits multiple vendors but does not guarantee awards. Investors await Redwire’s next earnings update, expected in early March.
28 January 2026
Redwire (RDW) stock jumps nearly 28% after landing $151 billion SHIELD defense contract slot

Redwire (RDW) stock jumps nearly 28% after landing $151 billion SHIELD defense contract slot

Redwire Corporation shares jumped nearly 28% to $14.01 Tuesday after announcing a spot on the Missile Defense Agency’s $151 billion SHIELD contract vehicle. The stock hit $14.54 intraday on heavy volume. The award is multi-vendor and does not guarantee revenue, Redwire said. Traders are watching for follow-up task orders and any impact on Redwire’s backlog or sales.
Redwire stock price jumps on Golden Dome buzz — what to watch when markets reopen

Redwire stock price jumps on Golden Dome buzz — what to watch when markets reopen

Redwire shares jumped 4.4% to $12.52 Friday, capping a two-day rally tied to speculation over President Trump’s “Golden Dome” missile-defense plan. Trading volume topped 50 million shares amid renewed focus on Arctic security and U.S. access to Greenland. H.C. Wainwright maintained a “Buy” rating and set a $22 target, citing possible new demand from Golden Dome. Key uncertainties remain over funding and contract timing.
25 January 2026
Redwire (RDW) stock price jumps again as ‘Golden Dome’ talk keeps buyers in the name

Redwire (RDW) stock price jumps again as ‘Golden Dome’ talk keeps buyers in the name

Redwire shares rose 11.4% to $13.34 by late Friday morning, following a 17.45% surge Thursday amid heavy trading and speculation over U.S. missile-defense plans tied to Greenland. Over 33 million shares traded Thursday, with options activity spiking. The company recently reorganized and launched an at-the-market equity program for up to $250 million. Investors await further details from Washington on the “Golden Dome” project.
Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire stock price today: RDW jumps in premarket after 17% surge as “Golden Dome” focus returns

Redwire Corp shares rose 9.9% premarket Friday after surging 17.5% Thursday, trading at $13.16. The rally follows renewed focus on the U.S. “Golden Dome” missile-defense system, with Redwire bidding for project work valued at $542 billion. H.C. Wainwright maintained its $22 price target. The company is restructuring and retiring the Edge Autonomy brand.
Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (RDW) Shares Plummet on Shake-Up – Is a Takeoff Next?

Redwire (NASDAQ:RDW) closed at about $9.40 on Oct. 15, down 1.5% after a 5.3% jump the previous day on news of a partnership with Red Cat. The stock remains volatile, falling 18.6% over the past week and down 42% year-to-date. CFO Jonathan Baliff will retire Nov. 30. Analysts’ 12-month price targets average $18–$19, with most ratings “Buy,” though Bank of America maintains an Underperform.
15 October 2025
Belgium’s Space Boom: From Small Nation to Satellite Powerhouse

Belgium’s Space Boom: From Small Nation to Satellite Powerhouse

Belgium contributed €296 million to the European Space Agency in 2024, ranking fifth among member states. The Belgian space sector employs about 6,500 people and includes over 400 organizations involved in ESA contracts. Major firms such as Thales Alenia Space Belgium and SABCA supply key components for European rockets and satellites. In 2024, Belgium signed the Artemis Accords and saw ESA select Raphaël Liégeois as its third astronaut.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:50 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Go toTop